Opendata, web and dolomites

HYPROTIN SIGNED

Hyperpolarized Nuclear Magnetic Resonance Spectroscopy for Time-Resolved Monitoring of Interactions of Intrinsically Disordered Breast-Cancer Proteins

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HYPROTIN project word cloud

Explore the words cloud of the HYPROTIN project. It provides you a very rough idea of what is the project "HYPROTIN" about.

nmr    methodological    treatment    idps    data    recognizing    nuclear    pioneering    medicinal    revolutionized    edge    disordered    thereby    hereditary    ovarian    hyperpolarization    characterization    facility    brca1    intrinsically    binding    lack    adding    mutation    risk    suited    consequence    technique    resolution    worldwide    structural    cutting    hyperpolarized    65    breast    revolutionize    hboc    overcome    base    proposes    interactome    platform    interaction    reconstitution    first    idp    limits    residue    sensitivity    dramatic    breaking    systematic    biologically    date    interdisciplinary    experimental    last    proteins    biology    goals    physiological    magnetic    molecular    protein    little    gene    unprecedented    biochemistry    experiments    hyprotin    drug    atomic    view    drugs    resonance    dimension    directed    resolved    time    ligand    mastectomy    decade    tumorigenesis    rational    cancer    ground    preventive    demanding    susceptibility    pi    huge    impedes    monitoring    kinetics    satisfactory    55    investigations    employ    medically   

Project "HYPROTIN" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAT WIEN 

Organization address
address: UNIVERSITATSRING 1
city: WIEN
postcode: 1010
website: www.univie.ac.at

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 1˙990˙728 €
 EC max contribution 1˙990˙728 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2024-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAT WIEN AT (WIEN) coordinator 1˙990˙728.00

Map

 Project objective

HYPROTIN proposes a pioneering research platform for hyperpolarized magnetic resonance of breast-cancer related proteins that will revolutionize our view on tumorigenesis at the atomic level, through bottom-up reconstitution of medicinal relevant interaction pathways involving the breast cancer susceptibility protein 1 (BRCA1). The risk to develop a hereditary breast or ovarian cancer (HBOC) increases to 55-65 % upon mutation of the BRCA1 gene. Yet, little is known about the biochemistry of tumorigenesis, so that drugs directed towards molecular targets are not satisfactory. To date, mastectomy remains the only preventive treatment. This dramatic lack of knowledge is a consequence of BRCA1 being an intrinsically disordered protein (IDP). Recognizing the importance of IDPs has revolutionized structural biology in the last decade, but this also represents a huge experimental challenge. To date, nuclear magnetic resonance (NMR) is the only technique available to study IDPs at high resolution. However, several limits of the technique must be overcome. Its low sensitivity impedes investigations under biologically meaningful conditions, so that new approaches are required. The HYPROTIN project aims to achieve two methodological goals: 1) Residue-resolved studies of the BRCA1 IDP under physiological conditions; and 2) real-time monitoring of BRCA1-ligand binding, thereby adding a time-resolved dimension to the NMR characterization of IDPs. This systematic approach will provide unprecedented insight into the BRCA1 interactome, provide medically relevant data and residue-resolved protein interaction kinetics. This will open a new knowledge base for rational drug design. The project will employ cutting-edge equipment that is unique worldwide, and will represent the first facility in Europe suited for these ground-breaking experiments. The PI has unique interdisciplinary experience enabling the demanding hyperpolarization approach to IDPs.

 Publications

year authors and title journal last update
List of publications.
2020 Gregory L. Olsen, Or Szekely, Borja Mateos, Pavel Kadeřávek, Fabien Ferrage, Robert Konrat, Roberta Pierattelli, Isabella C. Felli, Geoffrey Bodenhausen, Dennis Kurzbach, Lucio Frydman
Sensitivity-enhanced three-dimensional and carbon-detected two-dimensional NMR of proteins using hyperpolarized water
published pages: 161-171, ISSN: 0925-2738, DOI: 10.1007/s10858-020-00301-5
Journal of Biomolecular NMR 74/2-3 2020-04-15
2019 Sami Jannin, Jean-Nicolas Dumez, Patrick Giraudeau, Dennis Kurzbach
Application and methodology of dissolution dynamic nuclear polarization in physical, chemical and biological contexts
published pages: 41-50, ISSN: 1090-7807, DOI: 10.1016/j.jmr.2019.06.001
Journal of Magnetic Resonance 305 2019-09-04
2019 Giuseppe Sicoli, Hervé Vezin, Karin Ledolter, Thomas Kress, Dennis Kurzbach
Conformational tuning of a DNA-bound transcription factor
published pages: 5429-5435, ISSN: 0305-1048, DOI: 10.1093/nar/gkz291
Nucleic Acids Research 47/10 2019-08-05
2019 Thomas Kress, Astrid Walrant, Geoffrey Bodenhausen, Dennis Kurzbach
Long-Lived States in Hyperpolarized Deuterated Methyl Groups Reveal Weak Binding of Small Molecules to Proteins
published pages: 1523-1529, ISSN: 1948-7185, DOI: 10.1021/acs.jpclett.9b00149
The Journal of Physical Chemistry Letters 2019-05-28

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYPROTIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HYPROTIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

AllergenDetect (2019)

Comprehensive allergen detection using synthetic DNA libraries

Read More  

U-HEART (2018)

Unbreakable HEART: a reconfigurable and self-healing isolated dc/dc converter (U-HEART)

Read More  

RESOURCE Q (2019)

Efficient Conversion of Quantum Information Resources

Read More